Prehn, Jochen H M
Jirström, Elisabeth
Article History
Received: 12 December 2019
Accepted: 27 January 2020
First Online: 6 March 2020
Competing interests
: JHMP is a beneficiary of a patent relating to the use of angiogenin as a diagnostic and therapeutic for ALS and other neurodegenerative disorders. EJ declares no competing interest.